Precigen (PGEN) Tax Provisions (2014 - 2025)
Precigen (PGEN) reported Tax Provisions of $3000.0 for Q2 2025, up 100.18% year-over-year from $1498.7 in Q2 2024, and up 103.45% quarter-over-quarter from -$87000.0 in Q4 2024.
Precigen (PGEN) Tax Provisions (2014 - 2025) Analysis & Trends
Precigen (PGEN) has 12 years of Tax Provisions data on file, last reported at $3000.0 in Q2 2025.
- Tax Provisions for Q2 2025 came in at $3000.0, up 100.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $3000.0 (up 100.17% YoY), and the FY2025 annual result was $3000.0, up 100.17% from the prior year.
- Tax Provisions climbed to $3000.0 in Q2 2025 per PGEN's latest filing, from -$87000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $13000.0 in Q4 2021 and troughed at -$1.7 million in Q2 2024.
- A 5-year average of -$152764.7 and a median of -$55000.0 in 2023 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2023 and 2024: Tax Provisions slumped 4250.0% in 2023, then soared 300.0% in 2024.
- A 5-year view of Tax Provisions shows it stood at $13000.0 in 2021, then sank by 38.46% to $8000.0 in 2022, then tumbled by 4250.0% to -$332000.0 in 2023, then soared by 73.8% to -$87000.0 in 2024, then soared by 103.45% to $3000.0 in 2025.
- Business Quant data shows PGEN's Tax Provisions at $3000.0 in Q2 2025, -$87000.0 in Q4 2024, and $12000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 216,000.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 3,000.00 |
| Dec 31, 2024 | -87,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Jun 30, 2024 | -1.69 Mn |
| Mar 31, 2024 | -29,000.00 |
| Dec 31, 2023 | -332,000.00 |
| Sep 30, 2023 | -6,000.00 |
| Jun 30, 2023 | -65,000.00 |
| Mar 31, 2023 | -55,000.00 |
| Dec 31, 2022 | 8,000.00 |
| Sep 30, 2022 | -50,000.00 |
| Jun 30, 2022 | -89,000.00 |
| Mar 31, 2022 | -58,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Sep 30, 2021 | -61,000.00 |
| Jun 30, 2021 | -60,000.00 |
| Mar 31, 2021 | -52,000.00 |
| Dec 31, 2020 | 48,000.00 |
| Sep 30, 2020 | -50,000.00 |
| Jun 30, 2020 | -120,000.00 |